14Nov 2025
Early TNFi Use and Risk of Chronic Opioid Use in Axial Spondyloarthritis Patients

Early TNFi Use and Risk of Chronic Opioid Use in Axial Spondyloarthritis Patients

This retrospective cohort study evaluated whether early tumor necrosis factor inhibitor (TNFi) therapy reduces chronic opioid use among adults with axial spondyloarthritis (axSpA) using MarketScan data. Early TNFi initiation was not linked to lower risk of long-term opioid use, suggesting that timing of biologic therapy may not independently reduce opioid dependence in axSpA patients.

  • #rheumatology
  • #pharmacology

Like

Save

Share